Frequently Asked Questions Is compounded tirzepatide as safe and effective as Zepbound
Those Needing Medical Intervention Clinical obesity (BMI 30 or 27 with comorbidities), type 2 diabetes requiring management, or other metabolic conditions needing pharmaceutical treatment should not be addressed primarily through supplements marketed with misleading GLP-1 claims
In 2025, VMAIL reported that the American Optometric Association (AOA) had released a clinical report by their evidence-based optometry committee warning of some serious ocular complications associated with GLP-1 receptor agonists, including exacerbation of age-related macular degeneration, progression of diabetic retinopathy and the rare but serious onset of NAION
5- GSK (GlaxoSmithKline)_ *London, United Kingdom* A_Therapies:_ vaccines (Shingrix), HIV, respiratory, oncology
doi: 41
The potential use of plant natural products and plant extracts with antioxidant properties for the prevention/treatment of neurodegenerative diseases: in vitro, in vivo and clinical trials